Total Payments
$4,880
2024 Payments
$2,472
Companies
33
Transactions
312
Medicare Patients
1,659
Medicare Billing
$71,085
Payment Breakdown by Category
Food & Beverage$4,864 (99.7%)
Education$16.00 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,864 | 311 | 99.7% |
| Education | $16.00 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $813.51 | 55 | $0 (2024) |
| ABBVIE INC. | $687.84 | 57 | $0 (2024) |
| Lilly USA, LLC | $640.60 | 42 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $529.47 | 22 | $0 (2024) |
| GlaxoSmithKline, LLC. | $285.13 | 17 | $0 (2024) |
| PFIZER INC. | $263.44 | 21 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $219.48 | 15 | $0 (2024) |
| Amgen Inc. | $191.01 | 13 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $157.55 | 11 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $156.84 | 8 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,472 | 147 | AstraZeneca Pharmaceuticals LP ($393.76) |
| 2023 | $1,461 | 100 | Lilly USA, LLC ($298.66) |
| 2022 | $930.62 | 64 | Novo Nordisk Inc ($226.26) |
| 2021 | $16.00 | 1 | E.R. Squibb & Sons, L.L.C. ($16.00) |
All Payment Transactions
312 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $8.16 | General |
| Category: VACCINES | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Respiratory | ||||||
| 12/10/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: Diabetes | ||||||
| 12/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: Diabetes | ||||||
| 12/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $5.26 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Inflammation | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Gastroenterology | ||||||
| 12/01/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 11/26/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Respiratory | ||||||
| 11/15/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $10.71 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $12.30 | General |
| Category: PAIN | ||||||
| 11/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Respiratory | ||||||
| 10/30/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $33.54 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Gastroenterology | ||||||
| 10/22/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $26.78 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $9.42 | General |
| Category: DIABETES | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: Respiratory | ||||||
| 10/16/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: Neuroscience | ||||||
| 10/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: RESPIRATORY | ||||||
| 10/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: DIABETES | ||||||
| 10/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 388 | 619 | $69,254 | $22,359 |
| 2022 | 7 | 278 | 452 | $44,191 | $12,091 |
| 2021 | 13 | 489 | 802 | $43,743 | $17,082 |
| 2020 | 13 | 504 | 803 | $51,720 | $19,553 |
Total Patients
1,659
Total Services
2,676
Medicare Billing
$71,085
Procedure Codes
45
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 75 | 97 | $23,571 | $6,229 | 26.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 99 | 132 | $22,704 | $5,981 | 26.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 16 | 16 | $8,480 | $4,243 | 50.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 33 | 33 | $8,184 | $3,350 | 40.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 12 | 12 | $1,764 | $863.16 | 48.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 50 | 61 | $610.00 | $512.40 | 84.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 14 | 14 | $784.00 | $400.40 | 51.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 12 | 12 | $696.00 | $343.20 | 49.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 21 | 25 | $1,000 | $169.98 | 17.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 22 | 180 | $1,080 | $125.03 | 11.6% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 17 | 17 | $221.00 | $97.76 | 44.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 17 | 20 | $160.00 | $44.00 | 27.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 79 | 102 | $21,506 | $6,165 | 28.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 88 | 108 | $16,061 | $4,574 | 28.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $4,054 | $833.31 | 20.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 53 | 65 | $782.00 | $192.18 | 24.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 18 | 23 | $920.00 | $191.82 | 20.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 14 | 125 | $750.00 | $98.49 | 13.1% |
| 81003 | Automated urinalysis test | Office | 2022 | 13 | 16 | $118.00 | $35.67 | 30.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 147 | 219 | $25,334 | $10,506 | 41.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 47 | 60 | $9,096 | $2,374 | 26.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2021 | 39 | 58 | $1,825 | $974.40 | 53.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 45 | 51 | $952.00 | $538.56 | 56.6% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2021 | 37 | 40 | $1,000 | $535.60 | 53.6% |
| 82306 | Vitamin d-3 level | Office | 2021 | 14 | 15 | $670.00 | $444.00 | 66.3% |
About Shanna Langford
Shanna Langford is a Physician Assistant healthcare provider based in Lawrenceburg, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/24/2015. The National Provider Identifier (NPI) number assigned to this provider is 1992197222.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Shanna Langford has received a total of $4,880 in payments from pharmaceutical and medical device companies, with $2,472 received in 2024. These payments were reported across 312 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($4,864).
As a Medicare-enrolled provider, Langford has provided services to 1,659 Medicare beneficiaries, totaling 2,676 services with total Medicare billing of $71,085. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Lawrenceburg, KY
- Active Since 02/24/2015
- Last Updated 12/29/2022
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1992197222
Products in Payments
- MOUNJARO (Drug) $427.34
- Ozempic (Drug) $338.43
- VRAYLAR (Drug) $309.70
- AIRSUPRA (Drug) $288.01
- TRELEGY ELLIPTA (Drug) $285.13
- JARDIANCE (Drug) $218.66
- FARXIGA (Drug) $205.40
- UBRELVY (Drug) $189.18
- QULIPTA (Drug) $188.96
- Rybelsus (Drug) $172.16
- XIFAXAN (Drug) $157.55
- Otezla (Drug) $157.09
- Wegovy (Drug) $139.27
- REXULTI (Drug) $136.92
- NURTEC ODT (Drug) $127.38
- LEQVIO (Drug) $96.21
- SPRAVATO (Drug) $94.14
- ELIQUIS (Drug) $92.44
- Auvelity (Drug) $83.61
- Saxenda (Drug) $79.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Lawrenceburg
Sara Ackerman, Pa-C, PA-C
Physician Assistant — Payments: $5,339
Physician Assistant $5,339
Ms. Lacey Mccauley, Mms, Pa, MMS, PA
Physician Assistant — Payments: $4,507
Physician Assistant $4,507
Cynthia Mccann, Pac, PAC
Physician Assistant — Payments: $1,456
Physician Assistant $1,456
Rebecca Pfeiffer, Pa-C, PA-C
Physician Assistant — Payments: $1,455
Physician Assistant $1,455
Karrington Brooks, Pa-C, PA-C
Physician Assistant — Payments: $251.81
Physician Assistant $251.81
Victoria Copley, Pa-C, PA-C
Physician Assistant — Payments: $225.94
Physician Assistant $225.94